Advertisement

Research Article Free access | 10.1172/JCI119048

Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function.

S Riemersma, A Vincent, D Beeson, C Newland, S Hawke, B Vernet-der Garabedian, B Eymard, and J Newsom-Davis

Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

Find articles by Riemersma, S. in: PubMed | Google Scholar

Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

Find articles by Vincent, A. in: PubMed | Google Scholar

Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

Find articles by Beeson, D. in: PubMed | Google Scholar

Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

Find articles by Newland, C. in: PubMed | Google Scholar

Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

Find articles by Hawke, S. in: PubMed | Google Scholar

Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

Find articles by Vernet-der Garabedian, B. in: PubMed | Google Scholar

Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

Find articles by Eymard, B. in: PubMed | Google Scholar

Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

Find articles by Newsom-Davis, J. in: PubMed | Google Scholar

Published November 15, 1996 - More info

Published in Volume 98, Issue 10 on November 15, 1996
J Clin Invest. 1996;98(10):2358–2363. https://doi.org/10.1172/JCI119048.
© 1996 The American Society for Clinical Investigation
Published November 15, 1996 - Version history
View PDF
Abstract

Arthrogryposis multiplex congenita (AMC), characterized by multiple joint contractures developing in utero, results from lack of fetal movement. Some cases are genetically determined, but AMC occasionally complicates pregnancy in patients with myasthenia gravis (MG) suggesting involvement of circulating maternal antibodies. We previously demonstrated antibodies that inhibited the function of fetal acetylcholine receptor (AChR) in one healthy woman with an obstetric history of recurrent AMC. Here we study sera from this woman, from one other with a similar history, and from three (one asymptomatic) whose babies had neonatal MG and AMC. All five maternal sera had high titers of antibodies that inhibited alpha-Bungarotoxin (alpha-BuTx) binding to fetal AChR, and their sera markedly inhibited fetal AChR function with little effect on adult AChR function. Moreover, in a further survey, 3 of 20 sera from anti-AChR negative AMC mothers inhibited fetal AChR function significantly at 1:100 dilution. These results demonstrate the role of antibodies to fetal AChR and perhaps other muscle antigens in some cases of AMC. More generally, they suggest that placental transfer of antibodies directed at fetal antigens should be considered as a cause of other recurrent fetal or perinatal disorders.

Version history
  • Version 1 (November 15, 1996): No description
Advertisement
Advertisement